Uterine Artery embolization Flashcards
age range most women are typically affected by symptomatic adenomyosis
41-45 years old
long term symptom relief (12 months or more) after UAE for patients with purely adenomyosis
74%
de Brujin et al Uterine artery embolization for the treatment of adenomyosis JVIR 2017
circumstances where the junctional zone is difficult to visualize
- postmenopausal - myometrium looks like junx zone
- pregnancy - junx zone looks like myometrium
- premenarche
https://ajronline.org/doi/epdf/10.2214/AJR.10.4877
during which part of the menstrual cycle is the junctional zone at its maximal thickness
menstrual phase
phases of the menstrual cycle
- menstrual phase (1-4)
- early proliferative (5-9)
- late proliferative (10-14, estrogen effects dominate, trilaminar endometrium)
- secretory (15-28, progesterone effects dominate)
minstrels, prolife rally, secretary
if you see a thickened junx zone in a postmenopausal patient, you should ask if they are on ….
hormone replacement therapy
The types of adenomyosis seen on MRI
- Diffuse adenomyosis - entire junx zone is thickened
- focal adenomyosis - part of the junx zone is involved
- adenomyoma
risk factors for adenomyosis
- prior endouterine surgery
2. multiparity
Direct signs on MRI for adenomyosis diagnosis
- submucosal microcysts - usually located within the junx zone (but can also be found in outer myometrium)
- adenomyoma - well-delineated myometrial mass distinct from the junx zone
way to distinguish adenomyoma from leiomyoma
adenomyoma often will have high-signal intensity foci on T2
Indirect signs on MRI for adenomyosis
thickness of the junx zone
junctional zone thickness used when establishing the presence of adenomyosis
greater than 12 mm
what non-surgical or procedural treatment has found to be effective for treating adenomyosis
Mirena IUD, which is a levonorgestrel-releasing intrauterine system (lng-IUS)
what are the side effects for treating adenomyosis with a Mirena IUD
- weight gain (28.7%)
- ovarian cyst (22.3%)
- Lower abdominal pain (12.8%)
- Acne (6/4%)
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis
when is Mirena IUD unlikely to work
when the uterine volume is larger than 150 mL
Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis